Understanding how MLLT3 affects leukemia and blood cell development
AF9(MLLT3) Function in Leukemia and Normal Hematopoiesis
This study is looking at a protein called MLLT3 to understand how it affects leukemia and the growth of healthy blood cells, hoping to find new ways to treat leukemia that could help patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10667450 on NIH RePORTER |
What this research studies
This research investigates the role of the MLLT3 protein in leukemia and normal blood cell development. It focuses on how MLLT3 interacts with specific gene regulatory complexes that influence gene transcription. By examining the mechanisms of MLLT3 and its homolog MLLT1, the research aims to uncover how these proteins contribute to the development of leukemia and the regulation of blood cells. Patients may benefit from insights gained into potential new therapeutic targets for leukemia treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with leukemia or those with a family history of blood disorders.
Not a fit: Patients with solid tumors or non-hematological disorders may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for leukemia by targeting the mechanisms of gene regulation involved in the disease.
How similar studies have performed: Other research has shown promising results in targeting gene regulation mechanisms in leukemia, suggesting that this approach could be effective.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Bushweller, John Hackett — University of Virginia
- Study coordinator: Bushweller, John Hackett
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.